Results 161 to 170 of about 51,731 (234)

Atorvastatin Attenuates Human Cardiac Fibroblast Activation, with Associated Changes in GATA4/MEF2C and Selected Fibrosis-Related microRNAs. [PDF]

Int J Mol Sci
Chomaničová N, Adamičková A, Cervenak Z, Valášková S, Gažová A, Kyselovic J.   +5 more
europepmc   +1 more source

Atorvastatin and almonertinib-induced myopathy in a polypharmacy context: a case report. [PDF]

Front Cardiovasc Med
Zhou J, Yu L, Xu H.
europepmc   +1 more source

[Retracted] Atorvastatin increases lipopolysaccharide-induced expression of tumour necrosis factor-α-induced protein 8-like 2 in RAW264.7 cells. [PDF]

Exp Ther Med
Liu MW, Su MX, Zhang W, Wang L, Qian CY.
europepmc   +1 more source

Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives

, 2009
Madhuri Devabhaktuni1, Sripal Bangalore21Department of Medicine, Division of Cardiology, St Luke’s Roosevelt Hospital, Columbia University College of Physicians and Surgeons, New York, NY, USA; 2Brigham and Women’s Hospital, Harvard ...
Sripal Bangalore, Madhuri Devabhaktuni
core  

The Effect of Liraglutide on the Hypolipidemic, Anti-Inflammatory, and Antioxidant Properties of Atorvastatin Mediated via the Nrf2/HO-1 Signaling Pathway: In Vivo and In Silico Validation. [PDF]

Pharmaceutics
Kamar SA, Magdy YM, Abuamara TMM, Sedky AA, Al-Hazani TMI, Alhelf M, Zayed ES, A Yousef T, Al-Dakhil A, Abou-Krisha MM, Almehmadi SJ, Khedr S.   +11 more
europepmc   +1 more source

Effect of Atorvastatin Combined With Herb-Partitioned Moxibustion on PON-1 in Patients With Atherosclerotic Cerebral Infarction: A Randomized Controlled Trial. [PDF]

Brain Behav
An W, Hou X, Wei N, Zhou Y, Xie X, Jin Z, Wang L, Li X, Zhuang W, Chen D.   +9 more
europepmc   +1 more source

A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease. [PDF]

Am J Cardiovasc Drugs
Liu HH, Liu ZH, Chen SS, Zhu CG, Li JJ.
europepmc   +1 more source

High-throughput signal detection of hepatotoxic drug-drug interactions in hospitalized elderly patients: an NLP-driven pharmacovigilance study. [PDF]

Ann Med
Ma J, Chen H, Guo C, He G, Yang G.
europepmc   +1 more source

Short-term effect of rosuvastatin versus atorvastatin on the corrected QT interval: a target trial emulation. [PDF]

Eur J Clin Pharmacol
Chen X, Liu Y, Wei W, Xia X, Wu X, Lu X, Hu G, Lu S, Shen Y.   +8 more
europepmc   +1 more source

Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trial. [PDF]

Front Cardiovasc Med
Schäfer A, Großhennig A, Theis L, Schindler C, Grahl E, Stichtenoth DO, König T, Geller WA, Schmidt HHJG, Bavendiek U, Bauersachs J.   +10 more
europepmc   +1 more source